Gary P. Lawton, MD, FACS
Curriculum Vitae

Training: Resident in Plastic Surgery
Yale University School of Medicine
New Haven, Connecticut
1997-00
Honors: Corso Award for Plastic Surgery Research 1999, 2000
Training: Chief Resident in General Surgery
Yale University School of MedicineSurgical Research Fellow
Gastrointestinal Pathobiology Research Group
Yale University School of Medicine
1995-97

1993-95

Honors: American College of Surgeons Scholarship
for the Study of Wound HealingOhse Foundation Research Fellowship
Yale University Department of Surgery

Scientific Presentation Award
Association of VA Surgeons

Scientific Presentation Award
CT Society of American Board Surgeons

1993-1995

1993,1994

1994

1994

Training: Resident in General Surgery

Yale University School of Medicine

1990-93
Education: Doctor of Medicine

University of Massachusetts Medical School

Worcester, Massachusetts

1990
Honors: Senior Scholar in Surgery 1990
Education: Bachelor of Science, Chemical Engineering

Minor: Chemistry

University of Massachusetts at Amherst

1986
Honors: Summa cum laude

Departmental Honors, Second in Class

Tau Beta Pi Engineering Honor Society

Phi Kappa Phi Honor Society

Golden Key Honor Society

1986

1986

1985

1986

1986

 

Publications:

  1. Lawton G.P., Ariyan S., Rasque H., Perez A. Relationshipbetween fascia preservation and lymphedema after axillaryand ilioinguinofemoral lymphadenectomy for melanoma. In

    Press

  2. Ariyan S., Lawton G.P. Regional Lymph Node DissectionsIn: Malignant Melanoma. Clinics in Plastic Surgery. W. B.Saunders Co. Philadelphia. In Press
  3. Lawton G.P., Tang L. H., Kidd M., Chinery R., Miu K.,Modlin I. M. Regulation of mastomys ECL cell function bytransforming growth factor alpha. J Surg Research 1996,

    60(2):293-302.

  4. Lawton G.P., Tang L.H., Miu K., Gilligan C.J., Absood A.,Modlin I.M. Adrenergic and cromolyn sodium modulation of ECLcell histamine secretion. J Surg Research 1995, 58: 96-104.
  5. Lawton G.P., Modlin I.M. Recent advances in thelocalization and surgical management of duodenalgastrinomas. In: Current Opinion in General Surgery. Current

    Science, Philadelphia. 1994: 131-137.

  6. Modlin I.M., Lawton G.P. Duodenal gastrinoma: Solutionto the pancreatic paradox. J Clin Gastroenterol 1994, 19:184-188.
  7. Modlin I. M., Lawton G.P., Begos D. J. The dumpingsyndrome and postvagotomy diarrhea. In : Nyhus L. M. (ed)Mastery of Surgery, Third Edition, Little Brown and Company,

    Boston 1997.

  8. Modlin I.M., Lawton G.P., Miu K., Kidd M., Luque E.A.,Sandor A., Tang L.H. Pathophysiology of the fundicenterochromaffin-like (ECL) cell and gastric carcinoid

    tumours. Ann R Coll Surg Engl 1996, 78:133-138.

  9. Modlin I. M., Lawton G.P. Observations on the GallicGastric Illuminati. Perspectives in Biology and Medicine1996, 39(4)527-543.
  10. Gilligan C.J., Lawton G.P., Tang L.H., West A.B.,Modlin I.M. Gastric carcinoid tumors: The biology andtherapy of an enigmatic and controversial lesion. Am J

    Gastro 1995, 90: 338-352.

  11. Powers R. E., Lawton G.P., Modlin I. M. Genotoxicity andacid suppressing medications. Pharmacol and Therapeutics1995, 65:303-317
  12. Sgambati S., Lawton G.P., Modlin I.M. Chronicpancreatitis: A precursor to pancreatic carcinoma? DigSurgery 1994, 11:275-285.
  13. Modlin I.M., Lawton G.P. Evolution of an operativestrategy for diagnosis and management of duodenalgastrinomas. Journal of the American College of Surgeons.

    1994, 179: 611-625.

  14. Modlin I.M., Lawton G.P. The evolving clinical uses ofoctreotide. Drug Therapy 1994, 24: 28-38.
  15. Modlin I.M., Lawton G.P., Tang L.H., Geibel J., AbrahamR., Darr U. The mastomys gastric carcinoid: Aspects of ECLcell function. Digestion 1994, 55: 31-37.
  16. Modlin I.M., Gilligan C.J., Lawton G.P., Tang L.H., WestA.B. Observations on the relationship betweenhypergastrinemia, multiple gastric carcinoids, and a

    pancreatic mass. Dig Dis & Sci 1996, 41(1):105-114.

  17. Sandor A., Kidd M., Lawton G.P., Tang L. H., Miu K.,Modlin I. M. Neurohormonal modulation of ratenterochromaffin-like cell histamine secretion.

    Gastroenterology 1996, 110:1084-1092.

  18. Tang L.H., Modlin I.M., Lawton G.P., Kidd M., Chinery R.The role of transforming growth factor a in theenterochromaffin-like cell tumor autonomy in an African

    rodent Mastomys. Gastroenterology 1996, 111(5):1212-1223.

  19. Modlin I.M., Cornelius E., Lawton G.P. Use of anisotopic somatostatin receptor probe to image gut endocrinetumors. Archives of Surgery 1995, 130: 367-374.
  20. Modlin I.M., Gilligan C.J., Lawton G.P., Tang L.H., WestA.B., Darr U. Gastric Carcinoids: The Yale experience.Archives of Surgery 1995, 130(3)1250-1255.
  21. Modlin I.M., Goldenring J.R., Lawton G.P., Hunt R.J.Aspects of the theoretical basis and clinical relevance oflow acid states. American Journal of Gastroenterology 1994,

    89(3): 308-318.

  22. Modlin I.M., Tang L.H., Lawton G.P., Darr U., Zhu Z.H.,Soroka C.J. Enterochromaffin like cell pathobiology ofmastomys. Annals of the New York Academy of Sciences 1994,

    733: 365-379.

  23. Kidd M., Tang L.H., Miu K., Lawton G.P., Sandor A.,Modlin I.M. Autoregulation of enterochromaffin-like cellhistamine secretion via the histamine 3 receptor subtype.

    Yale J Biol and Med 1996, 69:9-19.

  24. Modlin I. M., Zhu Z. Z., Tang L. H., Kidd M., LawtonG.P., Miu K., Powers R. E. Goldenring J. R. Pasikov D.,Soroka C. J. Evidence for a regulatory role for histamine in

    gastric enterochromaffin-like cell proliferation induced by

    hypergastrinemia. Digestion 1996, 57:310-21.

Abstracts:

  1. Lawton G.P., Tang L.H., Miu K., Modlin I.M. The histamineand transforming growth factor alpha contribution to themucosal mitogenic cascade induced by gastrin. The 19th

    Annual Surgical Symposium of the Association of VA Surgeons,

    Pittsburgh, PA, 1995.

  2. Modlin I. M, Lawton G.P., Tang L. H., Miu K., Schwartz J.C. Histamine-3 receptor modulation of ECL cell histaminesecretion and DNA synthesis. American Gastroenterology

    Association, Abstract Supplement 1995, 108: A992 San Diego,

    CA, 1995.

  3. Tang L. H., Lawton G.P., Miu K., Modlin I. M. Alterationof the gastrin/CCK-B receptor by endogenous hypergastrinemiain transformed ECL cells. American Gastroenterology

    Association, Abstract Supplement 1995, 108:A1011 San Diego,

    CA, 1995.

  4. Modlin I. M., Lawton G.P., Tang L. H., Chinery R., WrightN. ECL cell TGFa production drives the gastrin-independentphase of ECL cell proliferation. American Gastroenterology

    Association, Abstract Supplement 1995, 108:A992 San Diego,

    CA, 1995.

  5. Cornelius E., Lawton G.P., Modlin I.M. Somatostatinreceptor scintigraphy of tumors. Fifth Conference onRadioimmunodetection and Radioimmunotherapy of Cancer,

    Orlando, FL, 1995.

  6. Cornelius E., Shi C., Lawton G.P., Modlin I. M.Octreotide scintigraphy: Comparison with CT and MR. Societyof Nuclear Medicine 42nd Annual Meeting, Minneapolis, MN,

    1995.

  7. Kidd M., Sandor A., Lawton G.P., Tang L. H., O’Keefe S.,Modlin I. M. The role of calcium channels in gastrin drivenECL cell histamine secretion. American Gastroenterology

    Association, Abstract Supplement 1995, 108:A627 San Diego,

    CA, 1995.

  8. Kidd M., Sandor A., Lawton G.P., Tang L. H., O’Keefe S.,Modlin I. M. Acetylcholine mediated enterochromaffin-like(ECL) cell modulation of the cephalic phase of acid

    secretion. American Gastroenterology Association, Abstract

    Supplement 1995, San Diego, CA, 1995.

  9. Sandor A., Kidd M., Lawton G.P., Tang L. H., O’Keefe S.,Modlin I. M. Neurotransmitter regulation of ECL cellhistamine secretion. American Gastroenterology Association,

    Abstract Supplement 1995, San Diego, CA, 1995.

  10. Lawton G.P., Tang L.H., Miu K., Modlin I.M. Modulationof enterochromaffin-like cell histamine secretion via a -adrenergic mechanism and the mast cell inhibitor sodium

    cromoglycate. The 18th Annual Surgical Symposium of the

    Association of VA Surgeons, Reno, Nevada, 1994.

  11. Modlin I.M., Lawton G.P., Cornelius E.A.. The surgicalutility of an isotopic somatostatin receptor probe toidentify gut neuroendocrine tumors and their metastases. New

    England Surgical Society, Newport, RI, 1994.

  12. Modlin I.M., Lawton G.P., Gilligan C.J., Tang L.H., DarrU, West A.B. The relationship between hypergastrinemia,gastric carcinoids and gastric adenocarcinoma in humans. New

    England Surgical Society, Newport, RI, 1994.

  13. Modlin I.M., Zhu Z.,Powers R.E., Goldenring J.R., TangL.H., Lawton G.P., Miu K., Soroka C. Tamoxifen modulatedhypergastrinemia amplifies gastric carcinoid tumor

    generation. Association of Academic Surgeons, Albuquerque,

    NM, 1994.

  14. Modlin I.M., Lawton G.P., Gilligan C.J., Tang L.H., DarrU, West A.B. Gastric carcinoid: The Connecticut experience.Connecticut Society of American Board Surgeons, Cromwell,

    CT, 1994.

  15. Tang L. H., Lawton G.P., Darr U., Modlin I.M. Protonpump inhibition down regulates enterochromaffin-like cellfunction. American Gastroenterology Association, Abstract

    Supplement 1994, New Orleans, LA 1994.

  16. Modlin I. M., Cornelius E., Lawton G.P. Somatostatinanalog scintigraphy in the localization ofgastroenteropancreatic neuroendocrine tumors. Connecticut

    Society of American Board Surgeons, Cromwell, CT, 1994.

  17. Abraham R. G., Lawton G.P., Tang L. H., Darr U., GeibelJ., Modlin I. M. ECL cell secretion is mediated by acalcium mechanism as characterized by both isolated cell and

    gland fluorescent video imaging and confocal microscopy.

    American Gastroenterology Association, Abstract Supplement

    1994, New Orleans, LA 1994.

  18. Biggs C., Lawton G.P., Tang L. H., Darr U., Modlin I.M. The cephalic phase of acid secretion may reflectcholinergic modulation of gastrin driven ECL cell histamine

    secretion. American Gastroenterology Association, Abstract

    Supplement 1994, New Orleans, LA 1994.

  19. Lawton G.P., Tang L.H., Miu K.,Darr U., Modlin I.M.Transforming growth factor alpha inhibits gastricenterochromaffin-like (ECL) cell secretion of histamine.

    Connecticut Society of American Board Surgeons, Cromwell,

    CT, 1994.

  20. Lawton G.P., Tang L.H., Saroka C., Darr U., Abraham R.,Modlin I.M. Characterization of isolated enterochromaffin-like cell function during parietal cell proton pump

    inhibition. Connecticut Society of American Board Surgeons,

    Cromwell, CT, 1993.

  21. Darr U., Lawton G.P., Abraham R.G, Modlin I.M. Gastriccarcinoid: Enigma or entity. Connecticut Society of AmericanBoard Surgeons, Cromwell, CT, 1993.
  22. Abraham R.G., Giebel J., Tang L.H., Lawton G.P., DarrU., Soroka C.J., Modlin I.M. Evaluation of ECL cellsecretory regulation utilizing image analysis of

    intracellular pH and calcium transients. Connecticut Society

    of American Board Surgeons, Cromwell, CT, 1993.

Presentations:

  1. 3-D anatomy of the malar fat pad. Yale Corso Award, 2000.
  2. Endoscopes in Plastic Surgery. Yale Plastic Surgery GrandRounds, 1999.
  3. Structural anatomy of the midface. Yale Corso Award,1999.
  4. Relationship between fascia preservation and lymphedemaafter axillary and ilioinguinofemoral lymphadenectomy formelanoma. New England Society of Plastic and Reconstructive

    Surgeons, Newport, RI, 1999.

  5. Craniofacial trauma: Historical perspectives. YalePlastic Surgery Grand Rounds, 1998.
  6. Controversies in replantation. Yale Plastic Surgery GrandRounds, 1997.
  7. Humours, tumours, and rumours. Yale Surgery Grand Rounds,1997.
  8. Transforming growth factor a regulates enterochromaffin-like cell tumor autonomy. The Gut as a Model in Cell andMolecular Biology, Freiburg, Germany, 1996.
  9. Surgical approach to thyroid and parathyroid pathology.Department of Surgery, Yale University School of Medicine,Resident Lecture Series, 1996.
  10. The histamine and transforming growth factor alphacontribution to the mucosal mitogenic cascade induced bygastrin. Assoc of VA Surgeons, Pittsburgh, PA, 1995.
  11. Carcinoid as a model of growth regulation inneuroendocrine tumors. Department of Surgery, YaleUniversity School of Medicine, Resident Lecture Series,

    1995.

  12. Tamoxifen modulated hypergastrinemia amplifies gastriccarcinoid tumor generation. Association of Academic Surgeons25th Annual Meeting, Albuquerque, NM 1994.
  13. Modulation of ECL cell histamine secretion via a -adrenergic mechanism. Assoc of VA Surgeons, Reno, Nevada,1994. Scientific Presentation Award.
  14. Transforming growth factor alpha inhibits gastricenterochromaffin-like cell secretion of histamine. CT Soc ofAm Board Surgeons, 1994. Scientific Presentation Award.
  15. Management priorities in maxillofacial trauma.Department of Surgery, Yale University School of Medicine,Resident Lecture Series, 1993.
  16. Gastric stromal tumors: Current pathologicalperspectives. Department of Surgery, Yale University Schoolof Medicine, Resident Lecture Series, 1992.
  17. Physikos Oinodotes: History of the medicinal uses ofwine. Department of Surgery, Yale University School ofMedicine, Resident Lecture Series, 1991.